CrpaA.18681.a
Aminoacyl-tRNA synthetase, probable; proline-tRNA synthetase
CENTER ID:
CrpaA.18681.a
ORGANISM:
Cryptosporidium parvum Iowa II
ASSOCIATED DISEASE:
cryptosporidiosis - (diarrheal disease)
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
CrpaA.18681.a.B1.GE38636
full length
info
1
688
CrpaA.18681.a.B1.GE38636
CrpaA.18681.a.B3.GE39089
soluble domain #2
info
186
688
CrpaA.18681.a.B3.GE39089
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
CrpaA.18681.a.B1.PW37640
full length
info
1
688
PW37640
Structures
5F9Y
DEPOSITED: 12/10/2015
DETERMINATION: XRay
CLONE: CrpaA.18681.a.B3.GE39089
PROTEIN: CrpaA.18681.a.B3.PW37711
5F9Z
DEPOSITED: 12/10/2015
DETERMINATION: XRay
CLONE: CrpaA.18681.a.B3.GE39089
PROTEIN: CrpaA.18681.a.B3.PW37711
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MSVDEKLYSE VLDQLSKLSI NYSKFDHDAT PNMESMVEVL KEQAEKHNTD FAKNLLIKSK GNEGLFFVLA HHETDTKMKN LGQIFGVSGN KLRLADEDVL NDTLKVKRGC LTPLSLIFEK SGGIQVYFDE CLKDKKVFVH PLTNTESFSI HINDIVKFAE SCGKKVKWFS MDNLEEQKPA GKPEESKENE SLLGITADKI TSFADWYSQV IVKSEMIEYY DISGCYILRP WSYFIWETIQ SVFDQKIKQH DVQNAYFPIF VTQKKLETEK DHVEGFSPEV AWVTKSGKSD LAEPIAIRPT SETIMYPYFA KWIRSHRDLP LKINQWTSIV RWEFKHPTPF IRTREFLWQE GHTAHSTRKE ALEMVDIILN EYASIYEDLL ATPVVKGTKS ENEKFPGGDI TKSIEGFIPE IGRAVQAATS HLLGQNFSKM FGVEFEDEKG NKEYAHQTSW GLTTRAIGVM IMTHGDNKGL VLPPKVAPVQ VIIIPIIFKT VITEEQKKIC NEVECILKKA GVRVKIDDRS NYTPGWKYNH WEVKGVCLRF EVGPRDIEKR SVRVVVRDNM EKMDIPISEL ESKIPKLLEE FQNRLLFKAK QRQNESIIRV DTFDKVMDTL NQKKMVIAPW CEDVSCEEEI KKETARLSLD NEDNQSMTGA MKSLCIPNDQ IFKIEEGKTK CFFCDKLAKK FTLFGRSY
NT Sequence
atgtcagtgg atgaaaaact atactccgag gtattagatc aattgagcaa gctctctata aactattcta agtttgatca tgatgctacc ccaaatatgg aatctatggt ggaagtgctt aaagagcagg cagaaaaaca caatactgac tttgcaaaaa atctattaat aaaatcaaaa ggtaacgaag gcttattttt tgttttggca caccacgaaa ccgatacgaa aatgaagaac cttgggcaga tctttggtgt gagtggaaac aagcttagat tagctgatga agatgtttta aatgatactc ttaaggtaaa aaggggatgc ttaactcctt tatctttaat atttgagaaa tctggaggaa ttcaagttta ctttgatgaa tgtcttaaag acaagaaagt atttgtacat ccactaacca atactgaaag cttttcaatc catattaatg acattgtaaa atttgctgaa tcatgtggga agaaagttaa atggttttct atggataatt tagaggaaca gaaacctgca ggaaagcctg aagaatctaa ggaaaacgaa agtttgcttg gaattacagc agacaaaata acttcttttg cagactggta ttcccaagtt atagtaaagt ctgaaatgat tgaatactat gatatctctg ggtgttacat attacgccca tggagttact ttatttggga aacaattcaa agcgttttcg atcagaaaat caaacaacat gatgtacaaa atgcctattt ccccattttt gtaacccaaa aaaagttaga aactgaaaaa gatcacgttg aaggattctc tcctgaagtt gcatgggtaa ctaaatcagg aaaatcagat ttagccgagc caatagctat ccgtccaaca tctgaaacaa tcatgtatcc atattttgcc aaatggatta gatcccatag ggatttgcca cttaagatta atcaatggac ttccattgta agatgggaat ttaagcatcc aactccattc atcagaacac gtgaattttt atggcaagaa ggacatacag cccattctac tagaaaagag gctttagaaa tggttgacat cattttaaat gaatatgcat ctatttatga agatttattg gcaactcctg tagttaaagg taccaaatct gagaatgaaa aattccctgg gggtgatata actaaatcaa ttgaaggatt cattccagaa attggtcgcg ctgttcaggc tgcaacttct catttacttg gacaaaactt tagcaaaatg tttggtgttg aatttgaaga tgaaaaagga aacaaagaat atgcacatca aacttcttgg ggcttaacta caagagctat tggtgttatg attatgacac atggagataa taaaggttta gtattgccac ctaaggttgc acctgtacaa gttattatta ttcccatcat ttttaaaacc gttatcactg aggaacagaa gaaaatctgc aatgaagtgg agtgtatttt gaagaaggct ggggttagag taaagatcga tgatagatct aactatactc ctggctggaa atataaccat tgggaagtta aaggtgtatg cttgagattt gaagttggac cgcgtgatat cgaaaagaga agtgttcgtg ttgttgttag agataatatg gagaaaatgg atattccaat ttccgaattg gaatcaaaga taccaaagtt gttggaagaa ttccaaaata gactgttatt taaggccaaa caacgacaaa atgaatctat cataagagtt gatacatttg acaaagttat ggatacactg aaccaaaaga agatggttat agctccttgg tgtgaggatg tatcatgcga ggaagaaatt aaaaaggaaa ctgcaagact tagtttggat aatgaagaca atcagtccat gaccggtgca atgaaatcct tgtgtatacc taatgatcaa atatttaaaa tagaagaagg aaaaacaaag tgtttcttct gtgataaact cgcaaagaaa tttacactat ttggaagaag ttactaa
Details for CrpaA.18681.a.B1.GE38636
HARVESTED ON:
11/19/2014
SEQUENCED ON:
12/10/2014
EXPECTED MW:
80kDa
OBSERVED MW:
80kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for CrpaA.18681.a.B3.GE39089
HARVESTED ON:
3/31/2015
SEQUENCED ON:
3/27/2015
EXPECTED MW:
59kDa
OBSERVED MW:
64kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
High Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
100
Details for CrpaA.18681.a.B1.PW37640
PURIFICATION DATe:
1/27/2015
CONCENTRATION:
24mg/ml
OBSERVED MW:
80kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
16
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable